Returning to Practice in the Post-COVID-19 Era: Hematology Disease EducationContains 3 Component(s) Includes a Live Web Event on 04/27/2021 at 3:00 PM (EDT)
Panelists will discuss considerations for resuming pre-pandemic level visits and procedures for patients with CLL, Acute , and Multiple Myeloma. Panelists will also discuss their wins and challenges with providing care to respective patients in a pandemic.
The COVID-19 Vaccine for Patients with CLL and Other CancersContains 3 Component(s)
The speaker will discuss considerations around the COVID-19 vaccines and interpret the respective NCCN guidance for patients with CLL and other cancers.
COVID-19 Implications for Cancer Clinical Research and Quality CareContains 3 Component(s)
The COVID-19 pandemic has thrown a wrench into every corner of the American healthcare system, and clinical research is no exception. In light of physical distancing and public safety recommendations, research programs have made significant adjustments, including virtual approaches to site selection and data collection and increased use of telehealth services. What lessons about clinical research can be learned during the pandemic, and what does it mean for the future of cancer research?
Financial Navigation During the COVID-19 Crisis: Tips From Financial AdvocatesContains 2 Component(s)
ACCC Financial Advocacy Network Town Hall
ASCO Survey on COVID-19 in Oncology (ASCO) RegistryContains 3 Component(s)
Join the Association of Community Cancer Centers (ACCC) and the American Society of Clinical Oncology (ASCO) for a webcast on how the COVID-19 pandemic presents a unique opportunity to better understand the effects of a disease outbreak on the delivery of high-quality cancer care and research.
Risk Stratification for Cancer Patients During COVID-19Contains 4 Component(s)
ACCC COVID-19 Webinar
Weathering the COVID-19 Storm: One Program's Care Coordination ExperienceContains 3 Component(s)
ACCC COVID-19 Webinar
Green Light for Cancer Research During COVID-19Contains 4 Component(s)
Clinical trials are critical to advancing cancer treatment, but keeping your research program afloat during a pandemic is a challenge. Learn strategies for sustaining a robust clinical trials program in uncertain times and how to increase the relevance of research to vulnerable and underserved patients.
|Access Date||Quiz Result||Score||Actions|